On Invalid Date, Accelerate Diagnostics (NASDAQ: AXDX) reported Q2 2023 earnings per share (EPS) of -$2.97, up 22.22% year over year. Total Accelerate Diagnostics earnings for the quarter were -$32.74 million. In the same quarter last year, Accelerate Diagnostics's earnings per share (EPS) was -$2.43.
As of Q3 2023, Accelerate Diagnostics's earnings has grown year over year. Accelerate Diagnostics's earnings in the past year totalled -$80.04 million.
What is AXDX's earnings date?
Accelerate Diagnostics's earnings date is Invalid Date. Add AXDX to your watchlist to be reminded of AXDX's next earnings announcement.
What was AXDX's revenue last quarter?
On Invalid Date, Accelerate Diagnostics (NASDAQ: AXDX) reported Q2 2023 revenue of $2.92 million up 24.35% year over year. In the same quarter last year, Accelerate Diagnostics's revenue was $3.86 million.
What was AXDX's revenue growth in the past year?
As of Q3 2023, Accelerate Diagnostics's revenue has grown -12.19% year over year. This is 18.12 percentage points lower than the US Medical Devices industry revenue growth rate of 5.93%. Accelerate Diagnostics's revenue in the past year totalled $11.67 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.